{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:01:04Z","timestamp":1791594064267,"version":"4.3.4"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R15 NS130532-01"],"award-info":[{"award-number":["R15 NS130532-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM 131732"],"award-info":[{"award-number":["GM 131732"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lewy body disorders are heterogeneous neurological conditions defined by intracellular inclusions composed of misshapen \u03b1-synuclein protein aggregates. Although \u03b1-synuclein aggregates are only one component of inclusions and not strictly coupled to neurodegeneration, evidence suggests they seed the propagation of Lewy pathology within and across cells. Genetic mutations, genomic multiplications, and sequence polymorphisms of the gene encoding \u03b1-synuclein are also causally linked to Lewy body disease. In nonfamilial cases of Lewy body disease, the disease trigger remains unidentified but may range from industrial\/agricultural toxicants and natural sources of poisons to microbial pathogens. Perhaps due to these peripheral exposures, Lewy inclusions appear at early disease stages in brain regions connected with cranial nerves I and X, which interface with inhaled and ingested environmental elements in the nasal or gastrointestinal cavities. Irrespective of its identity, a stealthy disease trigger most likely shifts soluble \u03b1-synuclein (directly or indirectly) into insoluble, cross-\u03b2-sheet aggregates. Indeed, \u03b2-sheet-rich self-replicating \u03b1-synuclein multimers reside in patient plasma, cerebrospinal fluid, and other tissues, and can be subjected to \u03b1-synuclein seed amplification assays. Thus, clinicians should be able to capitalize on \u03b1-synuclein seed amplification assays to stratify patients into potential responders <jats:italic>versus<\/jats:italic> non-responders in future clinical trials of \u03b1-synuclein targeted therapies. Here, we briefly review the current understanding of \u03b1-synuclein in Lewy body disease and speculate on pathophysiological processes underlying the potential transmission of \u03b1-synucleinopathy across the neuraxis.<\/jats:p>","DOI":"10.1007\/s00401-024-02781-3","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:02:00Z","timestamp":1723647720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Current insights and assumptions on \u03b1-synuclein in Lewy body disease"],"prefix":"10.1007","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-7417","authenticated-orcid":false,"given":"Rehana K.","family":"Leak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muslim","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin C.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"2781_CR1","doi-asserted-by":"publisher","first-page":"110090","DOI":"10.1016\/j.celrep.2021.110090","volume":"38","author":"MM Alam","year":"2022","unstructured":"Alam MM, Yang D, Li XQ, Liu J, Back TC, Trivett A et al (2022) Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function. Cell Rep 38:110090. https:\/\/doi.org\/10.1016\/j.celrep.2021.110090","journal-title":"Cell Rep"},{"key":"2781_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41531-023-00604-y","volume":"9","author":"MF Altay","year":"2023","unstructured":"Altay MF, Kumar ST, Burtscher J, Jagannath S, Strand C, Miki Y et al (2023) Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. NPJ Parkinsons Dis 9:161. https:\/\/doi.org\/10.1038\/s41531-023-00604-y","journal-title":"NPJ Parkinsons Dis"},{"key":"2781_CR3","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ et al (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739\u201329752. https:\/\/doi.org\/10.1074\/jbc.M600933200","journal-title":"J Biol Chem"},{"key":"2781_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1212\/wnl.49.2.610","volume":"49","author":"O Ansorge","year":"1997","unstructured":"Ansorge O, Daniel SE, Pearce RK (1997) Neuronal loss and plasticity in the supraoptic nucleus in Parkinson\u2019s disease. Neurology 49:610\u2013613. https:\/\/doi.org\/10.1212\/wnl.49.2.610","journal-title":"Neurology"},{"key":"2781_CR5","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1523\/JNEUROSCI.6194-10.2011","volume":"31","author":"S Anwar","year":"2011","unstructured":"Anwar S, Peters O, Millership S, Ninkina N, Doig N, Connor-Robson N et al (2011) Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J Neurosci 31:7264\u20137274. https:\/\/doi.org\/10.1523\/JNEUROSCI.6194-10.2011","journal-title":"J Neurosci"},{"key":"2781_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/wnl.51.3.887","volume":"51","author":"S Arawaka","year":"1998","unstructured":"Arawaka S, Saito Y, Murayama S, Mori H (1998) Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology 51:887\u2013889. https:\/\/doi.org\/10.1212\/wnl.51.3.887","journal-title":"Neurology"},{"key":"2781_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ana.26453","volume":"92","author":"MR Arnold","year":"2022","unstructured":"Arnold MR, Coughlin DG, Brumbach BH, Smirnov DS, Concha-Marambio L, Farris CM et al (2022) Alpha-synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological alpha-synuclein in the context of co-pathology and non-LBD diagnoses. Ann Neurol 92:650\u2013662. https:\/\/doi.org\/10.1002\/ana.26453","journal-title":"Ann Neurol"},{"key":"2781_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15:1257\u20131272. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7","journal-title":"Lancet Neurol"},{"key":"2781_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141:159\u2013172. https:\/\/doi.org\/10.1007\/s00401-020-02255-2","journal-title":"Acta Neuropathol"},{"key":"2781_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/hmg\/ddn417","volume":"18","author":"S Azeredo da Silveira","year":"2009","unstructured":"Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C, Sage D, Abbas-Terki T, Iwatsubo T et al (2009) Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson\u2019s disease. Hum Mol Genet 18:872\u2013887. https:\/\/doi.org\/10.1093\/hmg\/ddn417","journal-title":"Hum Mol Genet"},{"key":"2781_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40478-015-0209-z","volume":"3","author":"AD Bachstetter","year":"2015","unstructured":"Bachstetter AD, Van Eldik LJ, Schmitt FA, Neltner JH, Ighodaro ET, Webster SJ et al (2015) Disease-related microglia heterogeneity in the hippocampus of Alzheimer\u2019s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathol Commun 3:32. https:\/\/doi.org\/10.1186\/s40478-015-0209-z","journal-title":"Acta Neuropathol Commun"},{"key":"2781_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41589-024-01551-2","volume":"20","author":"AT Balana","year":"2024","unstructured":"Balana AT, Mahul-Mellier AL, Nguyen BA, Horvath M, Javed A, Hard ER et al (2024) O-GlcNAc forces an alpha-synuclein amyloid strain with notably diminished seeding and pathology. Nat Chem Biol 20:646\u2013655. https:\/\/doi.org\/10.1038\/s41589-024-01551-2","journal-title":"Nat Chem Biol"},{"key":"2781_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, White CL 3rd, Hladik CL, Sabbagh MN, Connor DJ, Shill HA et al (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169\u2013174. https:\/\/doi.org\/10.1007\/s00401-008-0450-7","journal-title":"Acta Neuropathol"},{"key":"2781_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J et al (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634. https:\/\/doi.org\/10.1007\/s00401-009-0538-8","journal-title":"Acta Neuropathol"},{"key":"2781_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL et al (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689\u2013702. https:\/\/doi.org\/10.1007\/s00401-010-0664-3","journal-title":"Acta Neuropathol"},{"key":"2781_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/NEN.0b013e3182805c72","volume":"72","author":"TG Beach","year":"2013","unstructured":"Beach TG, Adler CH, Dugger BN, Serrano G, Hidalgo J, Henry-Watson J et al (2013) Submandibular gland biopsy for the diagnosis of Parkinson disease. J Neuropathol Exp Neurol 72:130\u2013136. https:\/\/doi.org\/10.1097\/NEN.0b013e3182805c72","journal-title":"J Neuropathol Exp Neurol"},{"key":"2781_CR17","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/JVI.02949-15","volume":"90","author":"EL Beatman","year":"2015","unstructured":"Beatman EL, Massey A, Shives KD, Burrack KS, Chamanian M, Morrison TE et al (2015) Alpha-synuclein expression restricts RNA viral infections in the brain. J Virol 90:2767\u20132782. https:\/\/doi.org\/10.1128\/JVI.02949-15","journal-title":"J Virol"},{"key":"2781_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00401-023-02663-0","volume":"147","author":"GM Bentivenga","year":"2024","unstructured":"Bentivenga GM, Mammana A, Baiardi S, Rossi M, Ticca A, Magliocchetti F et al (2024) Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden. Acta Neuropathol 147:18. https:\/\/doi.org\/10.1007\/s00401-023-02663-0","journal-title":"Acta Neuropathol"},{"key":"2781_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fnins.2019.01399","volume":"13","author":"LD Bernal-Conde","year":"2019","unstructured":"Bernal-Conde LD, Ramos-Acevedo R, Reyes-Hernandez MA, Balbuena-Olvera AJ, Morales-Moreno ID, Arguero-Sanchez R et al (2019) Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles. Front Neurosci 13:1399. https:\/\/doi.org\/10.3389\/fnins.2019.01399","journal-title":"Front Neurosci"},{"key":"2781_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1789.2010.01117.x","volume":"31","author":"HG Bernstein","year":"2011","unstructured":"Bernstein HG, Johnson M, Perry RH, LeBeau FE, Dobrowolny H, Bogerts B et al (2011) Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies. Neuropathology 31:1\u201310. https:\/\/doi.org\/10.1111\/j.1440-1789.2010.01117.x","journal-title":"Neuropathology"},{"key":"2781_CR21","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s13311-021-01114-6","volume":"18","author":"TN Bhatia","year":"2021","unstructured":"Bhatia TN, Clark RN, Needham PG, Miner KM, Jamenis AS, Eckhoff EA et al (2021) Heat shock protein 70 as a sex-skewed regulator of alpha-synucleinopathy. Neurotherapeutics 18:2541\u20132564. https:\/\/doi.org\/10.1007\/s13311-021-01114-6","journal-title":"Neurotherapeutics"},{"key":"2781_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106196","author":"TN Bhatia","year":"2023","unstructured":"Bhatia TN, Jamenis AS, Abbas M, Clark RN, Miner KM, Chandwani MN et al (2023) A 14-day pulse of PLX5622 modifies alpha-synucleinopathy in preformed fibril-infused aged mice of both sexes. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2023.106196","journal-title":"Neurobiol Dis"},{"key":"2781_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrom L et al (2019) Parkinson\u2019s disease age at onset genome-wide association study: defining heritability, genetic loci, and alpha-synuclein mechanisms. Mov Disord 34:866\u2013875. https:\/\/doi.org\/10.1002\/mds.27659","journal-title":"Mov Disord"},{"key":"2781_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 19:170\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X","journal-title":"Lancet Neurol"},{"key":"2781_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A Bloch","year":"2006","unstructured":"Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32:284\u2013295. https:\/\/doi.org\/10.1111\/j.1365-2990.2006.00727.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2781_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer P (2021) The alpha-synuclein origin and connectome model (SOC Model) of Parkinson\u2019s disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline. J Parkinsons Dis 11:455\u2013474. https:\/\/doi.org\/10.3233\/JPD-202481","journal-title":"J Parkinsons Dis"},{"key":"2781_CR27","doi-asserted-by":"publisher","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S et al (2021) Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol Dis 161:105557. https:\/\/doi.org\/10.1016\/j.nbd.2021.105557","journal-title":"Neurobiol Dis"},{"key":"2781_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","volume":"8","author":"P Borghammer","year":"2022","unstructured":"Borghammer P, Just MK, Horsager J, Skjaerbaek C, Raunio A, Kok EH et al (2022) A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson\u2019s disease. NPJ Parkinsons Dis 8:166. https:\/\/doi.org\/10.1038\/s41531-022-00436-2","journal-title":"NPJ Parkinsons Dis"},{"key":"2781_CR29","doi-asserted-by":"crossref","unstructured":"Braak H, Muller CM, Rub U, Ackermann H, Bratzke H, de Vos RA, Del Tredici K (2006) Pathology associated with sporadic Parkinson's disease--where does it end? J Neural Transm Suppl 89\u201397","DOI":"10.1007\/978-3-211-45295-0_15"},{"key":"2781_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s004010051150","volume":"99","author":"H Braak","year":"2000","unstructured":"Braak H, Rub U, Sandmann-Keil D, Gai WP, de Vos RA, Jansen Steur EN et al (2000) Parkinson\u2019s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol 99:489\u2013495. https:\/\/doi.org\/10.1007\/s004010051150","journal-title":"Acta Neuropathol"},{"issue":"249 Suppl","key":"2781_CR31","doi-asserted-by":"publisher","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","volume":"3","author":"H Braak","year":"2002","unstructured":"Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J Neurol 3(249 Suppl):III\/1-5","journal-title":"J Neurol"},{"key":"2781_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"2781_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517\u2013536","journal-title":"J Neural Transm"},{"key":"2781_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"key":"2781_CR35","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1021\/ja5131726","volume":"137","author":"R Burai","year":"2015","unstructured":"Burai R, Ait-Bouziad N, Chiki A, Lashuel HA (2015) Elucidating the role of site-specific nitration of alpha-synuclein in the pathogenesis of Parkinson\u2019s disease via protein semisynthesis and mutagenesis. J Am Chem Soc 137:5041\u20135052. https:\/\/doi.org\/10.1021\/ja5131726","journal-title":"J Am Chem Soc"},{"key":"2781_CR36","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329:1663\u20131667. https:\/\/doi.org\/10.1126\/science.1195227","journal-title":"Science"},{"key":"2781_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024091","author":"J Burre","year":"2018","unstructured":"Burre J, Sharma M, Sudhof TC (2018) Cell biology and pathophysiology of alpha-synuclein. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a024091","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2781_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094861","author":"GA Carlson","year":"2021","unstructured":"Carlson GA, Prusiner SB (2021) How an infection of sheep revealed prion mechanisms in Alzheimer\u2019s disease and other neurodegenerative disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094861","journal-title":"Int J Mol Sci"},{"key":"2781_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/187152710791556140","volume":"9","author":"N Cavallarin","year":"2010","unstructured":"Cavallarin N, Vicario M, Negro A (2010) The role of phosphorylation in synucleinopathies: focus on Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 9:471\u2013481. https:\/\/doi.org\/10.2174\/187152710791556140","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2781_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/acn3.51753","volume":"10","author":"LM Chahine","year":"2023","unstructured":"Chahine LM, Beach TG, Adler CH, Hepker M, Kanthasamy A, Appel S et al (2023) Central and peripheral alpha-synuclein in Parkinson disease detected by seed amplification assay. Ann Clin Transl Neurol 10:696\u2013705. https:\/\/doi.org\/10.1002\/acn3.51753","journal-title":"Ann Clin Transl Neurol"},{"key":"2781_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JPD-225111","volume":"13","author":"LM Chahine","year":"2023","unstructured":"Chahine LM, Merchant K, Siderowf A, Sherer T, Tanner C, Marek K et al (2023) Proposal for a biologic staging system of Parkinson\u2019s disease. J Parkinsons Dis 13:297\u2013309. https:\/\/doi.org\/10.3233\/JPD-225111","journal-title":"J Parkinsons Dis"},{"key":"2781_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM et al (2020) Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci 23:327\u2013336. https:\/\/doi.org\/10.1038\/s41593-020-0589-7","journal-title":"Nat Neurosci"},{"key":"2781_CR43","doi-asserted-by":"publisher","first-page":"15313","DOI":"10.1074\/jbc.M213128200","volume":"278","author":"S Chandra","year":"2003","unstructured":"Chandra S, Chen X, Rizo J, Jahn R, Sudhof TC (2003) A broken alpha -helix in folded alpha-synuclein. J Biol Chem 278:15313\u201315318. https:\/\/doi.org\/10.1074\/jbc.M213128200","journal-title":"J Biol Chem"},{"key":"2781_CR44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123:383\u2013396. https:\/\/doi.org\/10.1016\/j.cell.2005.09.028","journal-title":"Cell"},{"key":"2781_CR45","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169. https:\/\/doi.org\/10.1016\/S0140-6736(04)17103-1","journal-title":"Lancet"},{"key":"2781_CR46","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1471-4159.2009.06191.x","volume":"110","author":"KY Chau","year":"2009","unstructured":"Chau KY, Ching HL, Schapira AH, Cooper JM (2009) Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson\u2019s disease pathogenesis. J Neurochem 110:1005\u20131013. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06191.x","journal-title":"J Neurochem"},{"key":"2781_CR47","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67:715\u2013725. https:\/\/doi.org\/10.1002\/ana.21995","journal-title":"Ann Neurol"},{"key":"2781_CR48","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K et al (2020) Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun 11:1386. https:\/\/doi.org\/10.1038\/s41467-020-15119-w","journal-title":"Nat Commun"},{"key":"2781_CR49","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.20.567854","author":"S Choi","year":"2024","unstructured":"Choi S, Tittle T, Garcia-Prada D, Kordower J, Melki R, Killinger B (2024) Alpha-synuclein aggregates are phosphatase resistant. bioRxiv. https:\/\/doi.org\/10.1101\/2023.11.20.567854","journal-title":"bioRxiv"},{"key":"2781_CR50","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1093\/brain\/awz296","volume":"142","author":"Y Chu","year":"2019","unstructured":"Chu Y, Muller S, Tavares A, Barret O, Alagille D, Seibyl J et al (2019) Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain 142:3565\u20133579. https:\/\/doi.org\/10.1093\/brain\/awz296","journal-title":"Brain"},{"key":"2781_CR51","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamaneurol.2015.0606","volume":"72","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Babulal GM, Monsell SE, Cairns NJ, Roe CM, Morris JC (2015) Clinical features of Alzheimer disease with and without lewy bodies. JAMA Neurol 72:789\u2013796. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0606","journal-title":"JAMA Neurol"},{"key":"2781_CR52","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1038\/s41598-020-61757-x","volume":"10","author":"J Courte","year":"2020","unstructured":"Courte J, Bousset L, Boxberg YV, Villard C, Melki R, Peyrin JM (2020) The expression level of alpha-synuclein in different neuronal populations is the primary determinant of its prion-like seeding. Sci Rep 10:4895. https:\/\/doi.org\/10.1038\/s41598-020-61757-x","journal-title":"Sci Rep"},{"key":"2781_CR53","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738305\/5688\/1292[pii]","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292\u20131295. https:\/\/doi.org\/10.1126\/science.1101738305\/5688\/1292[pii]","journal-title":"Science"},{"key":"2781_CR54","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1039\/c9em00578a","volume":"22","author":"BR De Miranda","year":"2020","unstructured":"De Miranda BR, Greenamyre JT (2020) Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson\u2019s disease. Environ Sci Process Impacts 22:543\u2013554. https:\/\/doi.org\/10.1039\/c9em00578a","journal-title":"Environ Sci Process Impacts"},{"key":"2781_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-212922","volume":"12","author":"BR De Miranda","year":"2022","unstructured":"De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER (2022) Preventing Parkinson\u2019s disease: an environmental agenda. J Parkinsons Dis 12:45\u201368. https:\/\/doi.org\/10.3233\/JPD-212922","journal-title":"J Parkinsons Dis"},{"key":"2781_CR56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413\u2013426","journal-title":"J Neuropathol Exp Neurol"},{"key":"2781_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng H, Wang P, Jankovic J (2018) The genetics of Parkinson disease. Ageing Res Rev 42:72\u201385. https:\/\/doi.org\/10.1016\/j.arr.2017.12.007","journal-title":"Ageing Res Rev"},{"key":"2781_CR58","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1038\/ncomms8314","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Newman AJ, Soldner F, Luth ES, Kim NC, von Saucken VE, Sanderson JB, Jaenisch R, Bartels T, Selkoe D (2015) Parkinson-causing alpha-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun 6:7314. https:\/\/doi.org\/10.1038\/ncomms8314","journal-title":"Nat Commun"},{"key":"2781_CR59","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1073\/pnas.1505953112","volume":"112","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Newman AJ, von Saucken VE, Bartels T, Selkoe D (2015) KTKEGV repeat motifs are key mediators of normal alpha-synuclein tetramerization: their mutation causes excess monomers and neurotoxicity. Proc Natl Acad Sci U S A 112:9596\u20139601. https:\/\/doi.org\/10.1073\/pnas.1505953112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2781_CR60","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","volume":"115","author":"DW Dickson","year":"2008","unstructured":"Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ et al (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease. Acta Neuropathol 115:437\u2013444. https:\/\/doi.org\/10.1007\/s00401-008-0345-7","journal-title":"Acta Neuropathol"},{"key":"2781_CR61","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/mds.25952","volume":"29","author":"AA Dijkstra","year":"2014","unstructured":"Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Netherlands Brain B, Rozemuller AJ et al (2014) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson\u2019s disease. Mov Disord 29:1244\u20131251. https:\/\/doi.org\/10.1002\/mds.25952","journal-title":"Mov Disord"},{"key":"2781_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41531-023-00574-1","volume":"9","author":"DJ Dues","year":"2023","unstructured":"Dues DJ, Nguyen APT, Becker K, Ma J, Moore DJ (2023) Hippocampal subfield vulnerability to alpha-synuclein pathology precedes neurodegeneration and cognitive dysfunction. NPJ Parkinsons Dis 9:125. https:\/\/doi.org\/10.1038\/s41531-023-00574-1","journal-title":"NPJ Parkinsons Dis"},{"key":"2781_CR63","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","volume":"15","author":"MF Duffy","year":"2018","unstructured":"Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG et al (2018) Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. J Neuroinflammation 15:129. https:\/\/doi.org\/10.1186\/s12974-018-1171-z","journal-title":"J Neuroinflammation"},{"key":"2781_CR64","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","volume":"17","author":"OM El-Agnaf","year":"2003","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ et al (2003) Alpha-synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma. FASEB J 17:1945\u20131947. https:\/\/doi.org\/10.1096\/fj.03-0098fje","journal-title":"FASEB J"},{"key":"2781_CR65","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA et al (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J 20:419\u2013425. https:\/\/doi.org\/10.1096\/fj.03-1449com","journal-title":"FASEB J"},{"key":"2781_CR66","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH et al (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30:6838\u20136851. https:\/\/doi.org\/10.1523\/JNEUROSCI.5699-09.2010","journal-title":"J Neurosci"},{"key":"2781_CR67","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molmed.2005.01.001","volume":"11","author":"JL Eriksen","year":"2005","unstructured":"Eriksen JL, Przedborski S, Petrucelli L (2005) Gene dosage and pathogenesis of Parkinson\u2019s disease. Trends Mol Med 11:91\u201396. https:\/\/doi.org\/10.1016\/j.molmed.2005.01.001","journal-title":"Trends Mol Med"},{"key":"2781_CR68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00401-017-1787-6","volume":"135","author":"D Erskine","year":"2018","unstructured":"Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J et al (2018) Regional levels of physiological alpha-synuclein are directly associated with Lewy body pathology. Acta Neuropathol 135:153\u2013154. https:\/\/doi.org\/10.1007\/s00401-017-1787-6","journal-title":"Acta Neuropathol"},{"key":"2781_CR69","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1212\/WNL.0000000000006926","volume":"92","author":"AJ Espay","year":"2019","unstructured":"Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A et al (2019) Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology 92:329\u2013337. https:\/\/doi.org\/10.1212\/WNL.0000000000006926","journal-title":"Neurology"},{"key":"2781_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/B978-0-323-85555-6.00004-7","volume":"193","author":"K Ezzat","year":"2023","unstructured":"Ezzat K, Espay AJ (2023) The allure and pitfalls of the prion-like aggregation in neurodegeneration. Handb Clin Neurol 193:17\u201322. https:\/\/doi.org\/10.1016\/B978-0-323-85555-6.00004-7","journal-title":"Handb Clin Neurol"},{"key":"2781_CR71","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M et al (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174\u2013179. https:\/\/doi.org\/10.1002\/ana.10846","journal-title":"Ann Neurol"},{"key":"2781_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nbd.2013.03.014","volume":"56","author":"F Febbraro","year":"2013","unstructured":"Febbraro F, Sahin G, Farran A, Soares S, Jensen PH, Kirik D et al (2013) Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson\u2019s disease. Neurobiol Dis 56:47\u201358. https:\/\/doi.org\/10.1016\/j.nbd.2013.03.014","journal-title":"Neurobiol Dis"},{"key":"2781_CR73","doi-asserted-by":"publisher","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","volume":"294","author":"JM Froula","year":"2019","unstructured":"Froula JM, Castellana-Cruz M, Anabtawi NM, Camino JD, Chen SW, Thrasher DR et al (2019) Defining alpha-synuclein species responsible for Parkinson\u2019s disease phenotypes in mice. J Biol Chem 294:10392\u201310406. https:\/\/doi.org\/10.1074\/jbc.RA119.007743","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"2781_CR74","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S1353-8020(13)70010-5","volume":"20","author":"S Fujioka","year":"2014","unstructured":"Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK (2014) Update on novel familial forms of Parkinson\u2019s disease and multiple system atrophy. Parkinsonism Relat Disord 20(Suppl 1):S29-34. https:\/\/doi.org\/10.1016\/S1353-8020(13)70010-5","journal-title":"Parkinsonism Relat Disord"},{"key":"2781_CR75","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS et al (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"2781_CR76","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/nen.0b013e3180517454","volume":"66","author":"Y Fumimura","year":"2007","unstructured":"Fumimura Y, Ikemura M, Saito Y, Sengoku R, Kanemaru K, Sawabe M et al (2007) Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 66:354\u2013362. https:\/\/doi.org\/10.1097\/nen.0b013e3180517454","journal-title":"J Neuropathol Exp Neurol"},{"key":"2781_CR77","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"HM Gao","year":"2008","unstructured":"Gao HM, Hong JS (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 29:357\u2013365. https:\/\/doi.org\/10.1016\/j.it.2008.05.002","journal-title":"Trends Immunol"},{"key":"2781_CR78","doi-asserted-by":"publisher","first-page":"626128","DOI":"10.3389\/fncel.2021.626128","volume":"15","author":"NZ Gcwensa","year":"2021","unstructured":"Gcwensa NZ, Russell DL, Cowell RM, Volpicelli-Daley LA (2021) Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s disease. Front Cell Neurosci 15:626128. https:\/\/doi.org\/10.3389\/fncel.2021.626128","journal-title":"Front Cell Neurosci"},{"key":"2781_CR79","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361\u2013372. https:\/\/doi.org\/10.1016\/0896-6273(95)90040-3","journal-title":"Neuron"},{"key":"2781_CR80","doi-asserted-by":"publisher","first-page":"e2109617119","DOI":"10.1073\/pnas.2109617119","volume":"119","author":"SS Ghanem","year":"2022","unstructured":"Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM et al (2022) Alpha-synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci USA 119:e2109617119. https:\/\/doi.org\/10.1073\/pnas.2109617119","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR81","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51:745\u2013752. https:\/\/doi.org\/10.1136\/jnnp.51.6.745","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2781_CR82","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0792","author":"CH Gibbons","year":"2024","unstructured":"Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J et al (2024) Skin biopsy detection of phosphorylated alpha-synuclein in patients with synucleinopathies. JAMA. https:\/\/doi.org\/10.1001\/jama.2024.0792","journal-title":"JAMA"},{"key":"2781_CR83","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492\u2013501. https:\/\/doi.org\/10.1038\/35081564","journal-title":"Nat Rev Neurosci"},{"key":"2781_CR84","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M (2015) NEURODEGENERATION. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science 349:1255555. https:\/\/doi.org\/10.1126\/science.1255555","journal-title":"Science"},{"key":"2781_CR85","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0959-4388(98)80090-1","volume":"8","author":"M Goedert","year":"1998","unstructured":"Goedert M, Spillantini MG, Davies SW (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8:619\u2013632","journal-title":"Curr Opin Neurobiol"},{"key":"2781_CR86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100 years of Lewy pathology. Nat Rev Neurol 9:13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2012.242","journal-title":"Nat Rev Neurol"},{"key":"2781_CR87","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/bs.pbr.2020.02.005","volume":"252","author":"P Gonzalez-Rodriguez","year":"2020","unstructured":"Gonzalez-Rodriguez P, Zampese E, Surmeier DJ (2020) Selective neuronal vulnerability in Parkinson\u2019s disease. Prog Brain Res 252:61\u201389. https:\/\/doi.org\/10.1016\/bs.pbr.2020.02.005","journal-title":"Prog Brain Res"},{"key":"2781_CR88","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1073\/pnas.0711053105","volume":"105","author":"OS Gorbatyuk","year":"2008","unstructured":"Gorbatyuk OS, Li S, Sullivan LF, Chen W, Kondrikova G, Manfredsson FP et al (2008) The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc Natl Acad Sci USA 105:763\u2013768. https:\/\/doi.org\/10.1073\/pnas.0711053105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR89","doi-asserted-by":"publisher","first-page":"19573","DOI":"10.1073\/pnas.1005005107","volume":"107","author":"B Greten-Harrison","year":"2010","unstructured":"Greten-Harrison B, Polydoro M, Morimoto-Tomita M, Diao L, Williams AM, Nie EH et al (2010) alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci USA 107:19573\u201319578. https:\/\/doi.org\/10.1073\/pnas.1005005107","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR90","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1074\/jbc.M114.585703","volume":"290","author":"M Grey","year":"2015","unstructured":"Grey M, Dunning CJ, Gaspar R, Grey C, Brundin P, Sparr E et al (2015) Acceleration of alpha-synuclein aggregation by exosomes. J Biol Chem 290:2969\u20132982. https:\/\/doi.org\/10.1074\/jbc.M114.585703","journal-title":"J Biol Chem"},{"key":"2781_CR91","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/nar\/gkn084","volume":"36","author":"J Grundemann","year":"2008","unstructured":"Grundemann J, Schlaudraff F, Haeckel O, Liss B (2008) Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson\u2019s disease. Nucleic Acids Res 36:e38. https:\/\/doi.org\/10.1093\/nar\/gkn084","journal-title":"Nucleic Acids Res"},{"key":"2781_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021136","author":"A Gualerzi","year":"2024","unstructured":"Gualerzi A, Picciolini S, Bedoni M, Guerini FR, Clerici M, Agliardi C (2024) Extracellular vesicles as biomarkers for Parkinson\u2019s disease: how far from clinical translation? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25021136","journal-title":"Int J Mol Sci"},{"key":"2781_CR93","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M, Wang J, Zhao Y, Feng Y, Han S, Dong Q et al (2020) Microglial exosomes facilitate alpha-synuclein transmission in Parkinson\u2019s disease. Brain 143:1476\u20131497. https:\/\/doi.org\/10.1093\/brain\/awaa090","journal-title":"Brain"},{"key":"2781_CR94","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378\u2013384","journal-title":"Brain Pathol"},{"key":"2781_CR95","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00109-019-01810-z","volume":"97","author":"C Han","year":"2019","unstructured":"Han C, Xiong N, Guo X, Huang J, Ma K, Liu L et al (2019) Exosomes from patients with Parkinson\u2019s disease are pathological in mice. J Mol Med (Berl) 97:1329\u20131344. https:\/\/doi.org\/10.1007\/s00109-019-01810-z","journal-title":"J Mol Med (Berl)"},{"key":"2781_CR96","doi-asserted-by":"publisher","first-page":"104076","DOI":"10.1016\/j.ebiom.2022.104076","volume":"80","author":"Y Han","year":"2022","unstructured":"Han Y, Wu D, Wang Y, Xie J, Zhang Z (2022) Skin alpha-synuclein deposit patterns: a predictor of Parkinson\u2019s disease subtypes. EBioMedicine 80:104076. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104076","journal-title":"EBioMedicine"},{"key":"2781_CR97","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/mds.25077","volume":"27","author":"MA Harris","year":"2012","unstructured":"Harris MA, Tsui JK, Marion SA, Shen H, Teschke K (2012) Association of Parkinson\u2019s disease with infections and occupational exposure to possible vectors. Mov Disord 27:1111\u20131117. https:\/\/doi.org\/10.1002\/mds.25077","journal-title":"Mov Disord"},{"key":"2781_CR98","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33:599\u2013614. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00874.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2781_CR99","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","volume":"1170","author":"CH Hawkes","year":"2009","unstructured":"Hawkes CH, Del Tredici K, Braak H (2009) Parkinson\u2019s disease: the dual hit theory revisited. Ann N Y Acad Sci 1170:615\u2013622. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04365.x","journal-title":"Ann N Y Acad Sci"},{"key":"2781_CR100","doi-asserted-by":"publisher","first-page":"578047","DOI":"10.1016\/j.jneuroim.2023.578047","volume":"376","author":"DL Heiden","year":"2023","unstructured":"Heiden DL, Monogue B, Ali MDH, Beckham JD (2023) A functional role for alpha-synuclein in neuroimmune responses. J Neuroimmunol 376:578047. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578047","journal-title":"J Neuroimmunol"},{"key":"2781_CR101","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","volume":"22","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Cornblath EJ, Darwich A, Zhang B, Brown H, Gathagan RJ et al (2019) Spread of alpha-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nat Neurosci 22:1248\u20131257. https:\/\/doi.org\/10.1038\/s41593-019-0457-5","journal-title":"Nat Neurosci"},{"key":"2781_CR102","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00401-020-02163-5","volume":"142","author":"SAM Holec","year":"2021","unstructured":"Holec SAM, Woerman AL (2021) Evidence of distinct alpha-synuclein strains underlying disease heterogeneity. Acta Neuropathol 142:73\u201386. https:\/\/doi.org\/10.1007\/s00401-020-02163-5","journal-title":"Acta Neuropathol"},{"key":"2781_CR103","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K et al (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci USA 110:E3138-3147. https:\/\/doi.org\/10.1073\/pnas.1301440110","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR104","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2004.05.100","volume":"367","author":"AD Hope","year":"2004","unstructured":"Hope AD, Myhre R, Kachergus J, Lincoln S, Bisceglio G, Hulihan M et al (2004) Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson\u2019s disease. Neurosci Lett 367:97\u2013100. https:\/\/doi.org\/10.1016\/j.neulet.2004.05.100","journal-title":"Neurosci Lett"},{"key":"2781_CR105","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13024-022-00564-6","volume":"17","author":"M Iba","year":"2022","unstructured":"Iba M, McDevitt RA, Kim C, Roy R, Sarantopoulou D, Tommer E et al (2022) Aging exacerbates the brain inflammatory micro-environment contributing to alpha-synuclein pathology and functional deficits in a mouse model of DLB\/PD. Mol Neurodegener 17:60. https:\/\/doi.org\/10.1186\/s13024-022-00564-6","journal-title":"Mol Neurodegener"},{"key":"2781_CR106","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ibanez","year":"2004","unstructured":"Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P et al (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet 364:1169\u20131171. https:\/\/doi.org\/10.1016\/S0140-6736(04)17104-3","journal-title":"Lancet"},{"key":"2781_CR107","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneurol.2008.555","volume":"66","author":"P Ibanez","year":"2009","unstructured":"Ibanez P, Lesage S, Janin S, Lohmann E, Durif F, Destee A et al (2009) Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Arch Neurol 66:102\u2013108. https:\/\/doi.org\/10.1001\/archneurol.2008.555","journal-title":"Arch Neurol"},{"key":"2781_CR108","doi-asserted-by":"publisher","first-page":"9008","DOI":"10.1038\/s41598-017-08720-5","volume":"7","author":"E Ihse","year":"2017","unstructured":"Ihse E, Yamakado H, van Wijk XM, Lawrence R, Esko JD, Masliah E (2017) Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type. Sci Rep 7:9008. https:\/\/doi.org\/10.1038\/s41598-017-08720-5","journal-title":"Sci Rep"},{"key":"2781_CR109","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-004-0919-y","volume":"109","author":"K Imamura","year":"2005","unstructured":"Imamura K, Hishikawa N, Ono K, Suzuki H, Sawada M, Nagatsu T et al (2005) Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol 109:141\u2013150. https:\/\/doi.org\/10.1007\/s00401-004-0919-y","journal-title":"Acta Neuropathol"},{"key":"2781_CR110","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","volume":"57","author":"MC Irizarry","year":"1998","unstructured":"Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF et al (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson\u2019s disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334\u2013337. https:\/\/doi.org\/10.1097\/00005072-199804000-00005","journal-title":"J Neuropathol Exp Neurol"},{"key":"2781_CR111","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41531-023-00583-0","volume":"9","author":"N Ito","year":"2023","unstructured":"Ito N, Tsuji M, Adachi N, Nakamura S, Sarkar AK, Ikenaka K et al (2023) Extracellular high molecular weight alpha-synuclein oligomers induce cell death by disrupting the plasma membrane. NPJ Parkinsons Dis 9:139. https:\/\/doi.org\/10.1038\/s41531-023-00583-0","journal-title":"NPJ Parkinsons Dis"},{"key":"2781_CR112","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-x","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA et al (1995) The precursor protein of non-A beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467\u2013475. https:\/\/doi.org\/10.1016\/0896-6273(95)90302-x","journal-title":"Neuron"},{"key":"2781_CR113","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1212\/wnl.52.6.1269","volume":"52","author":"K Iwanaga","year":"1999","unstructured":"Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H et al (1999) Lewy body-type degeneration in cardiac plexus in Parkinson\u2019s and incidental Lewy body diseases. Neurology 52:1269\u20131271. https:\/\/doi.org\/10.1212\/wnl.52.6.1269","journal-title":"Neurology"},{"key":"2781_CR114","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker M, Walker LC (2018) Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci 21:1341\u20131349. https:\/\/doi.org\/10.1038\/s41593-018-0238-6","journal-title":"Nat Neurosci"},{"key":"2781_CR115","doi-asserted-by":"publisher","first-page":"e2312306120","DOI":"10.1073\/pnas.2312306120","volume":"121","author":"K Kakuda","year":"2024","unstructured":"Kakuda K, Ikenaka K, Kuma A, Doi J, Aguirre C, Wang N et al (2024) Lysophagy protects against propagation of alpha-synuclein aggregation through ruptured lysosomal vesicles. Proc Natl Acad Sci USA 121:e2312306120. https:\/\/doi.org\/10.1073\/pnas.2312306120","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1750-3639.2011.00509.x","volume":"22","author":"T Kanazawa","year":"2012","unstructured":"Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T (2012) Pale neurites, premature alpha-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol 22:67\u201378. https:\/\/doi.org\/10.1111\/j.1750-3639.2011.00509.x","journal-title":"Brain Pathol"},{"key":"2781_CR117","doi-asserted-by":"publisher","first-page":"105654","DOI":"10.1016\/j.nbd.2022.105654","volume":"166","author":"A Kasen","year":"2022","unstructured":"Kasen A, Houck C, Burmeister AR, Sha Q, Brundin L, Brundin P (2022) Upregulation of alpha-synuclein following immune activation: possible trigger of Parkinson\u2019s disease. Neurobiol Dis 166:105654. https:\/\/doi.org\/10.1016\/j.nbd.2022.105654","journal-title":"Neurobiol Dis"},{"key":"2781_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116216","author":"I Kawahata","year":"2022","unstructured":"Kawahata I, Finkelstein DI, Fukunaga K (2022) Pathogenic impact of alpha-synuclein phosphorylation and its kinases in alpha-synucleinopathies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23116216","journal-title":"Int J Mol Sci"},{"key":"2781_CR119","doi-asserted-by":"publisher","first-page":"e1011920","DOI":"10.1371\/journal.ppat.1011920","volume":"20","author":"CR Khedmatgozar","year":"2024","unstructured":"Khedmatgozar CR, Holec SAM, Woerman AL (2024) The role of alpha-synuclein prion strains in Parkinson\u2019s disease and multiple system atrophy. PLoS Pathog 20:e1011920. https:\/\/doi.org\/10.1371\/journal.ppat.1011920","journal-title":"PLoS Pathog"},{"issue":"627\u2013641","key":"2781_CR120","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S et al (2019) Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103(627\u2013641):e627. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"key":"2781_CR121","doi-asserted-by":"publisher","first-page":"909273","DOI":"10.3389\/fnagi.2022.909273","volume":"14","author":"IH Klaestrup","year":"2022","unstructured":"Klaestrup IH, Just MK, Holm KL, Alstrup AKO, Romero-Ramos M, Borghammer P et al (2022) Impact of aging on animal models of Parkinson\u2019s disease. Front Aging Neurosci 14:909273. https:\/\/doi.org\/10.3389\/fnagi.2022.909273","journal-title":"Front Aging Neurosci"},{"key":"2781_CR122","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1212\/01.wnl.0000204179.88955.fa","volume":"66","author":"KJ Klos","year":"2006","unstructured":"Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF et al (2006) Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology 66:1100\u20131102. https:\/\/doi.org\/10.1212\/01.wnl.0000204179.88955.fa","journal-title":"Neurology"},{"key":"2781_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29766","author":"A Kluge","year":"2024","unstructured":"Kluge A, Schaeffer E, Bunk J, Sommerauer M, Rottgen S, Schulte C et al (2024) Detecting misfolded alpha-synuclein in blood years before the diagnosis of Parkinson\u2019s disease. Mov Disord. https:\/\/doi.org\/10.1002\/mds.29766","journal-title":"Mov Disord"},{"key":"2781_CR124","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14:504\u2013506. https:\/\/doi.org\/10.1038\/nm1747","journal-title":"Nat Med"},{"key":"2781_CR125","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-022-01403-x","volume":"10","author":"DJ Koss","year":"2022","unstructured":"Koss DJ, Erskine D, Porter A, Palmoski P, Menon H, Todd OGJ et al (2022) Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathol Commun 10:98. https:\/\/doi.org\/10.1186\/s40478-022-01403-x","journal-title":"Acta Neuropathol Commun"},{"key":"2781_CR126","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x","volume":"45","author":"R Kruger","year":"1999","unstructured":"Kruger R, Vieira-Saecker AM, Kuhn W, Berg D, Muller T, Kuhnl N et al (1999) Increased susceptibility to sporadic Parkinson\u2019s disease by a certain combined alpha-synuclein\/apolipoprotein E genotype. Ann Neurol 45:611\u2013617. https:\/\/doi.org\/10.1002\/1531-8249(199905)45:5%3c611::aid-ana9%3e3.0.co;2-x","journal-title":"Ann Neurol"},{"key":"2781_CR127","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00401-015-1408-1","volume":"129","author":"M Kunadt","year":"2015","unstructured":"Kunadt M, Eckermann K, Stuendl A, Gong J, Russo B, Strauss K et al (2015) Extracellular vesicle sorting of alpha-synuclein is regulated by sumoylation. Acta Neuropathol 129:695\u2013713. https:\/\/doi.org\/10.1007\/s00401-015-1408-1","journal-title":"Acta Neuropathol"},{"key":"2781_CR128","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38\u201348. https:\/\/doi.org\/10.1038\/nrn3406","journal-title":"Nat Rev Neurosci"},{"key":"2781_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2024.05.017","author":"DF Lazaro","year":"2024","unstructured":"Lazaro DF, Lee VM (2024) Navigating through the complexities of synucleinopathies: insights into pathogenesis, heterogeneity, and future perspectives. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2024.05.017","journal-title":"Neuron"},{"key":"2781_CR130","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00401-019-02057-1","volume":"138","author":"RK Leak","year":"2019","unstructured":"Leak RK, Frosch MP, Beach TG, Halliday GM (2019) Alpha-synuclein: prion or prion-like? Acta Neuropathol 138:509\u2013514. https:\/\/doi.org\/10.1007\/s00401-019-02057-1","journal-title":"Acta Neuropathol"},{"key":"2781_CR131","doi-asserted-by":"publisher","first-page":"e1010670","DOI":"10.1371\/journal.ppat.1010670","volume":"18","author":"P Leblanc","year":"2022","unstructured":"Leblanc P, Vorberg IM (2022) Viruses in neurodegenerative diseases: more than just suspects in crimes. PLoS Pathog 18:e1010670. https:\/\/doi.org\/10.1371\/journal.ppat.1010670","journal-title":"PLoS Pathog"},{"key":"2781_CR132","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1096\/fj.00-0334com","volume":"15","author":"FJ Lee","year":"2001","unstructured":"Lee FJ, Liu F, Pristupa ZB, Niznik HB (2001) Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 15:916\u2013926. https:\/\/doi.org\/10.1096\/fj.00-0334com","journal-title":"FASEB J"},{"key":"2781_CR133","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25:6016\u20136024. https:\/\/doi.org\/10.1523\/JNEUROSCI.0692-05.2005","journal-title":"J Neurosci"},{"key":"2781_CR134","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature05453","volume":"445","author":"ES Lein","year":"2007","unstructured":"Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A et al (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168\u2013176. https:\/\/doi.org\/10.1038\/nature05453","journal-title":"Nature"},{"key":"2781_CR135","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","volume":"17","author":"JB Leverenz","year":"2007","unstructured":"Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW et al (2007) Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 17:139\u2013145. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00048.x","journal-title":"Brain Pathol"},{"key":"2781_CR136","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1750-3639.2007.00117.x","volume":"18","author":"JB Leverenz","year":"2008","unstructured":"Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB et al (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18:220\u2013224. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00117.x","journal-title":"Brain Pathol"},{"issue":"1086\u20131093","key":"2781_CR137","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1016\/j.neuron.2022.12.029","volume":"111","author":"KS Levine","year":"2023","unstructured":"Levine KS, Leonard HL, Blauwendraat C, Iwaki H, Johnson N, Bandres-Ciga S et al (2023) Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111(1086\u20131093):e1082. https:\/\/doi.org\/10.1016\/j.neuron.2022.12.029","journal-title":"Neuron"},{"key":"2781_CR138","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14:501\u2013503. https:\/\/doi.org\/10.1038\/nm1746","journal-title":"Nat Med"},{"key":"2781_CR139","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/mds.23012","volume":"25","author":"JY Li","year":"2010","unstructured":"Li JY, Englund E, Widner H, Rehncrona S, Bjorklund A, Lindvall O et al (2010) Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson\u2019s disease. Mov Disord 25:1091\u20131096. https:\/\/doi.org\/10.1002\/mds.23012","journal-title":"Mov Disord"},{"key":"2781_CR140","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/pmic.201300342","volume":"14","author":"V Licker","year":"2014","unstructured":"Licker V, Turck N, Kovari E, Burkhardt K, Cote M, Surini-Demiri M et al (2014) Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson\u2019s disease pathogenesis. Proteomics 14:784\u2013794. https:\/\/doi.org\/10.1002\/pmic.201300342","journal-title":"Proteomics"},{"key":"2781_CR141","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40478-024-01805-z","volume":"12","author":"GM Lloyd","year":"2024","unstructured":"Lloyd GM, Quintin S, Sorrentino ZA, Gorion KM, Bell BM, Long B et al (2024) A multiverse of alpha-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models. Acta Neuropathol Commun 12:91. https:\/\/doi.org\/10.1186\/s40478-024-01805-z","journal-title":"Acta Neuropathol Commun"},{"key":"2781_CR142","doi-asserted-by":"publisher","first-page":"691136","DOI":"10.3389\/fncel.2021.691136","volume":"15","author":"SK Lotz","year":"2021","unstructured":"Lotz SK, Blackhurst BM, Reagin KL, Funk KE (2021) Microbial infections are a risk factor for neurodegenerative diseases. Front Cell Neurosci 15:691136. https:\/\/doi.org\/10.3389\/fncel.2021.691136","journal-title":"Front Cell Neurosci"},{"key":"2781_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512116","author":"PM Loveland","year":"2023","unstructured":"Loveland PM, Yu JJ, Churilov L, Yassi N, Watson R (2023) Investigation of inflammation in Lewy body dementia: a systematic scoping review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241512116","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"2781_CR144","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S1353-8020(13)70022-1","volume":"20","author":"KC Luk","year":"2014","unstructured":"Luk KC, Lee VM (2014) Modeling Lewy pathology propagation in Parkinson\u2019s disease. Parkinsonism Relat Disord 20(Suppl 1):S85-87. https:\/\/doi.org\/10.1016\/S1353-8020(13)70022-1","journal-title":"Parkinsonism Relat Disord"},{"key":"2781_CR145","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR et al (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 106:20051\u201320056. https:\/\/doi.org\/10.1073\/pnas.0908005106","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR146","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209:975\u2013986. https:\/\/doi.org\/10.1084\/jem.20112457","journal-title":"J Exp Med"},{"key":"2781_CR147","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ et al (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953. https:\/\/doi.org\/10.1126\/science.1227157","journal-title":"Science"},{"key":"2781_CR148","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.febslet.2015.10.023","volume":"589","author":"E Luna","year":"2015","unstructured":"Luna E, Luk KC (2015) Bent out of shape: alpha-synuclein misfolding and the convergence of pathogenic pathways in Parkinson\u2019s disease. FEBS Lett 589:3749\u20133759. https:\/\/doi.org\/10.1016\/j.febslet.2015.10.023","journal-title":"FEBS Lett"},{"key":"2781_CR149","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00401-018-1829-8","volume":"135","author":"E Luna","year":"2018","unstructured":"Luna E, Decker SC, Riddle DM, Caputo A, Zhang B, Cole T et al (2018) Differential alpha-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Acta Neuropathol 135:855\u2013875. https:\/\/doi.org\/10.1007\/s00401-018-1829-8","journal-title":"Acta Neuropathol"},{"key":"2781_CR150","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/mds.10258","volume":"17","author":"V MacDonald","year":"2002","unstructured":"MacDonald V, Halliday GM (2002) Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson\u2019s disease. Mov Disord 17:1166\u20131173. https:\/\/doi.org\/10.1002\/mds.10258","journal-title":"Mov Disord"},{"key":"2781_CR151","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1212\/wnl.55.1.132","volume":"55","author":"IR Mackenzie","year":"2000","unstructured":"Mackenzie IR (2000) Activated microglia in dementia with Lewy bodies. Neurology 55:132\u2013134. https:\/\/doi.org\/10.1212\/wnl.55.1.132","journal-title":"Neurology"},{"key":"2781_CR152","doi-asserted-by":"publisher","first-page":"e4951","DOI":"10.1002\/pro.4951","volume":"33","author":"A Mahapatra","year":"2024","unstructured":"Mahapatra A, Newberry RW (2024) Liquid-liquid phase separation of alpha-synuclein is highly sensitive to sequence complexity. Protein Sci 33:e4951. https:\/\/doi.org\/10.1002\/pro.4951","journal-title":"Protein Sci"},{"key":"2781_CR153","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-016-0072-9","volume":"11","author":"NK Majbour","year":"2016","unstructured":"Majbour NK, Vaikath NN, van Dijk KD, Ardah MT, Varghese S, Vesterager LB et al (2016) Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease. Mol Neurodegener 11:7. https:\/\/doi.org\/10.1186\/s13024-016-0072-9","journal-title":"Mol Neurodegener"},{"key":"2781_CR154","doi-asserted-by":"publisher","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","volume":"285","author":"SK Mak","year":"2010","unstructured":"Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA (2010) Lysosomal degradation of alpha-synuclein in vivo. J Biol Chem 285:13621\u201313629. https:\/\/doi.org\/10.1074\/jbc.M109.074617","journal-title":"J Biol Chem"},{"key":"2781_CR155","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne S, Kondru N, Jin H, Anantharam V, Huang X, Kanthasamy A et al (2020) alpha-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients. Mov Disord 35:268\u2013278. https:\/\/doi.org\/10.1002\/mds.27907","journal-title":"Mov Disord"},{"key":"2781_CR156","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804\u20132815. https:\/\/doi.org\/10.1523\/JNEUROSCI.08-08-02804.1988","journal-title":"J Neurosci"},{"key":"2781_CR157","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-016-0113-4","volume":"11","author":"DM Mason","year":"2016","unstructured":"Mason DM, Nouraei N, Pant DB, Miner KM, Hutchison DF, Luk KC et al (2016) Transmission of alpha-synucleinopathy from olfactory structures deep into the temporal lobe. Mol Neurodegener 11:49. https:\/\/doi.org\/10.1186\/s13024-016-0113-4","journal-title":"Mol Neurodegener"},{"key":"2781_CR158","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bpa.12718","volume":"29","author":"DM Mason","year":"2019","unstructured":"Mason DM, Wang Y, Bhatia TN, Miner KM, Trbojevic SA, Stolz JF et al (2019) The center of olfactory bulb-seeded alpha-synucleinopathy is the limbic system and the ensuing pathology is higher in male than in female mice. Brain Pathol 29:741\u2013770. https:\/\/doi.org\/10.1111\/bpa.12718","journal-title":"Brain Pathol"},{"key":"2781_CR159","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/NEN.0b013e3181a24b53","volume":"68","author":"NR McFarland","year":"2009","unstructured":"McFarland NR, Fan Z, Xu K, Schwarzschild MA, Feany MB, Hyman BT et al (2009) Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. J Neuropathol Exp Neurol 68:515\u2013524. https:\/\/doi.org\/10.1097\/NEN.0b013e3181a24b53","journal-title":"J Neuropathol Exp Neurol"},{"key":"2781_CR160","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131291. https:\/\/doi.org\/10.1212\/wnl.38.8.1285","journal-title":"Neurology"},{"key":"2781_CR161","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"key":"2781_CR162","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","volume":"14","author":"RM Meade","year":"2019","unstructured":"Meade RM, Fairlie DP, Mason JM (2019) Alpha-synuclein structure and Parkinson\u2019s disease\u2014lessons and emerging principles. Mol Neurodegener 14:29. https:\/\/doi.org\/10.1186\/s13024-019-0329-1","journal-title":"Mol Neurodegener"},{"key":"2781_CR163","doi-asserted-by":"publisher","first-page":"104623","DOI":"10.1016\/j.nbd.2019.104623","volume":"134","author":"C Mezias","year":"2020","unstructured":"Mezias C, Rey N, Brundin P, Raj A (2020) Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: involvement of retrograde and anterograde axonal propagation. Neurobiol Dis 134:104623. https:\/\/doi.org\/10.1016\/j.nbd.2019.104623","journal-title":"Neurobiol Dis"},{"key":"2781_CR164","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","volume":"79","author":"JM Milber","year":"2012","unstructured":"Milber JM, Noorigian JV, Morley JF, Petrovitch H, White L, Ross GW et al (2012) Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease. Neurology 79:2307\u20132314. https:\/\/doi.org\/10.1212\/WNL.0b013e318278fe32","journal-title":"Neurology"},{"key":"2781_CR165","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1212\/01.wnl.0000127517.33208.f4","volume":"62","author":"DW Miller","year":"2004","unstructured":"Miller DW, Hague SM, Clarimon J, Baptista M, Gwinn-Hardy K, Cookson MR et al (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62:1835\u20131838. https:\/\/doi.org\/10.1212\/01.wnl.0000127517.33208.f4","journal-title":"Neurology"},{"key":"2781_CR166","doi-asserted-by":"publisher","first-page":"102307","DOI":"10.1016\/j.pneurobio.2022.102307","volume":"216","author":"KM Miner","year":"2022","unstructured":"Miner KM, Jamenis AS, Bhatia TN, Clark RN, Rajasundaram D, Sauvaigo S et al (2022) alpha-synucleinopathy exerts sex-dimorphic effects on the multipurpose DNA repair\/redox protein APE1 in mice and humans. Prog Neurobiol 216:102307. https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102307","journal-title":"Prog Neurobiol"},{"key":"2781_CR167","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-023-02621-w","volume":"146","author":"KM Miner","year":"2023","unstructured":"Miner KM, Jamenis AS, Bhatia TN, Clark RN, Abbas M, Luk KC et al (2023) The variance in phosphorylated, insoluble \u237a-synuclein in humans, rats, and mice is not mainly driven by biological sex. Acta Neuropathol 146:651\u2013654. https:\/\/doi.org\/10.1007\/s00401-023-02621-w","journal-title":"Acta Neuropathol"},{"key":"2781_CR168","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JPD-230183","volume":"14","author":"TE Moors","year":"2024","unstructured":"Moors TE, Milovanovic D (2024) Defining a Lewy body: running up the hill of shifting definitions and evolving concepts. J Parkinsons Dis 14:17\u201333. https:\/\/doi.org\/10.3233\/JPD-230183","journal-title":"J Parkinsons Dis"},{"key":"2781_CR169","doi-asserted-by":"publisher","first-page":"844211","DOI":"10.3389\/fncel.2022.844211","volume":"16","author":"E Moretto","year":"2022","unstructured":"Moretto E, Stuart S, Surana S, Vargas JNS, Schiavo G (2022) The role of extracellular matrix components in the spreading of pathological protein aggregates. Front Cell Neurosci 16:844211. https:\/\/doi.org\/10.3389\/fncel.2022.844211","journal-title":"Front Cell Neurosci"},{"key":"2781_CR170","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/ana.410430612","volume":"43","author":"MD Muenter","year":"1998","unstructured":"Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ et al (1998) Hereditary form of parkinsonism\u2013dementia. Ann Neurol 43:768\u2013781. https:\/\/doi.org\/10.1002\/ana.410430612","journal-title":"Ann Neurol"},{"key":"2781_CR171","doi-asserted-by":"publisher","first-page":"167713","DOI":"10.1016\/j.jmb.2022.167713","volume":"435","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee S, Sakunthala A, Gadhe L, Poudyal M, Sawner AS, Kadu P et al (2023) Liquid-liquid phase separation of alpha-synuclein: a new mechanistic insight for alpha-synuclein aggregation associated with Parkinson\u2019s disease pathogenesis. J Mol Biol 435:167713. https:\/\/doi.org\/10.1016\/j.jmb.2022.167713","journal-title":"J Mol Biol"},{"key":"2781_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13090881","author":"S Nandipati","year":"2016","unstructured":"Nandipati S, Litvan I (2016) Environmental exposures and Parkinson\u2019s disease. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph13090881","journal-title":"Int J Environ Res Public Health"},{"key":"2781_CR173","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s004010000224","volume":"100","author":"M Neumann","year":"2000","unstructured":"Neumann M, Adler S, Schluter O, Kremmer E, Benecke R, Kretzschmar HA (2000) Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol 100:568\u2013574. https:\/\/doi.org\/10.1007\/s004010000224","journal-title":"Acta Neuropathol"},{"key":"2781_CR174","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neurobiolaging.2020.02.026","volume":"91","author":"N Ninkina","year":"2020","unstructured":"Ninkina N, Tarasova TV, Chaprov KD, Roman AY, Kukharsky MS, Kolik LG et al (2020) Alterations in the nigrostriatal system following conditional inactivation of alpha-synuclein in neurons of adult and aging mice. Neurobiol Aging 91:76\u201387. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.02.026","journal-title":"Neurobiol Aging"},{"key":"2781_CR175","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","volume":"299","author":"N Nouraei","year":"2018","unstructured":"Nouraei N, Mason DM, Miner KM, Carcella MA, Bhatia TN, Dumm BK et al (2018) Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders. Exp Neurol 299:172\u2013196. https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.017","journal-title":"Exp Neurol"},{"issue":"75\u201390","key":"2781_CR176","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.neuron.2018.09.014","volume":"100","author":"S Nuber","year":"2018","unstructured":"Nuber S, Rajsombath M, Minakaki G, Winkler J, Muller CP, Ericsson M et al (2018) Abrogating native alpha-synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome closely resembling Parkinson\u2019s disease. Neuron 100(75\u201390):e75. https:\/\/doi.org\/10.1016\/j.neuron.2018.09.014","journal-title":"Neuron"},{"key":"2781_CR177","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41531-024-00662-w","volume":"10","author":"S Nuber","year":"2024","unstructured":"Nuber S, Zhang X, McCaffery TD, Moors TE, Adom MA, Hahn WN et al (2024) Generation of G51D and 3D mice reveals decreased alpha-synuclein tetramer-monomer ratios promote Parkinson\u2019s disease phenotypes. NPJ Parkinsons Dis 10:47. https:\/\/doi.org\/10.1038\/s41531-024-00662-w","journal-title":"NPJ Parkinsons Dis"},{"key":"2781_CR178","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.275.1.390","volume":"275","author":"M Okochi","year":"2000","unstructured":"Okochi M, Walter J, Koyama A, Nakajo S, Baba M, Iwatsubo T et al (2000) Constitutive phosphorylation of the Parkinson\u2019s disease associated alpha-synuclein. J Biol Chem 275:390\u2013397. https:\/\/doi.org\/10.1074\/jbc.275.1.390","journal-title":"J Biol Chem"},{"key":"2781_CR179","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","volume":"109","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T et al (2005) Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 109:583\u2013588. https:\/\/doi.org\/10.1007\/s00401-005-0995-7","journal-title":"Acta Neuropathol"},{"key":"2781_CR180","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/acn3.51280","volume":"8","author":"CD Orru","year":"2021","unstructured":"Orru CD, Ma TC, Hughson AG, Groveman BR, Srivastava A, Galasko D et al (2021) A rapid alpha-synuclein seed assay of Parkinson\u2019s disease CSF panel shows high diagnostic accuracy. Ann Clin Transl Neurol 8:374\u2013384. https:\/\/doi.org\/10.1002\/acn3.51280","journal-title":"Ann Clin Transl Neurol"},{"key":"2781_CR181","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JPD-160779","volume":"6","author":"A Oueslati","year":"2016","unstructured":"Oueslati A (2016) Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade? J Parkinsons Dis 6:39\u201351. https:\/\/doi.org\/10.3233\/JPD-160779","journal-title":"J Parkinsons Dis"},{"key":"2781_CR182","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","volume":"62","author":"L Parkkinen","year":"2003","unstructured":"Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 62:363\u2013367","journal-title":"J Neuropathol Exp Neurol"},{"key":"2781_CR183","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JPD-2011-11046","volume":"1","author":"L Parkkinen","year":"2011","unstructured":"Parkkinen L, O\u2019Sullivan SS, Collins C, Petrie A, Holton JL, Revesz T et al (2011) Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson\u2019s disease. J Parkinsons Dis 1:277\u2013286. https:\/\/doi.org\/10.3233\/JPD-2011-11046","journal-title":"J Parkinsons Dis"},{"key":"2781_CR184","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O et al (2019) CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol 18:573\u2013586. https:\/\/doi.org\/10.1016\/S1474-4422(19)30024-9","journal-title":"Lancet Neurol"},{"issue":"4006\u20134023","key":"2781_CR185","doi-asserted-by":"publisher","first-page":"e4010","DOI":"10.1016\/j.neuron.2023.11.020","volume":"111","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas LA, Madhivanan K, Aulston BD, Wang L, Prakashchand DD, Boyer NP et al (2023) Serine-129 phosphorylation of alpha-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron 111(4006\u20134023):e4010. https:\/\/doi.org\/10.1016\/j.neuron.2023.11.020","journal-title":"Neuron"},{"key":"2781_CR186","doi-asserted-by":"publisher","first-page":"104525","DOI":"10.1016\/j.nbd.2019.104525","volume":"130","author":"JR Patterson","year":"2019","unstructured":"Patterson JR, Duffy MF, Kemp CJ, Howe JW, Collier TJ, Stoll AC et al (2019) Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal alpha-synuclein preformed fibrils. Neurobiol Dis 130:104525. https:\/\/doi.org\/10.1016\/j.nbd.2019.104525","journal-title":"Neurobiol Dis"},{"key":"2781_CR187","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier KL, Luk KC, Manfredsson FP, Kanaan NM, Lipton JW, Collier TJ et al (2015) Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol Dis 82:185\u2013199. https:\/\/doi.org\/10.1016\/j.nbd.2015.06.003","journal-title":"Neurobiol Dis"},{"key":"2781_CR188","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00401-023-02562-4","volume":"145","author":"W Peelaerts","year":"2023","unstructured":"Peelaerts W, Mercado G, George S, Villumsen M, Kasen A, Aguileta M et al (2023) Urinary tract infections trigger synucleinopathy via the innate immune response. Acta Neuropathol 145:541\u2013559. https:\/\/doi.org\/10.1007\/s00401-023-02562-4","journal-title":"Acta Neuropathol"},{"key":"2781_CR189","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng C, Trojanowski JQ, Lee VM (2020) Protein transmission in neurodegenerative disease. Nat Rev Neurol 16:199\u2013212. https:\/\/doi.org\/10.1038\/s41582-020-0333-7","journal-title":"Nat Rev Neurol"},{"key":"2781_CR190","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","volume":"22","author":"RG Perez","year":"2002","unstructured":"Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090\u20133099","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"2781_CR191","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.parkreldis.2015.08.015","volume":"22","author":"S Petrucci","year":"2016","unstructured":"Petrucci S, Ginevrino M, Valente EM (2016) Phenotypic spectrum of alpha-synuclein mutations: new insights from patients and cellular models. Parkinsonism Relat Disord 22(Suppl 1):S16-20. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.015","journal-title":"Parkinsonism Relat Disord"},{"key":"2781_CR192","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncom.2013.00013","volume":"7","author":"EK Pissadaki","year":"2013","unstructured":"Pissadaki EK, Bolam JP (2013) The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson\u2019s disease. Front Comput Neurosci 7:13. https:\/\/doi.org\/10.3389\/fncom.2013.00013","journal-title":"Front Comput Neurosci"},{"key":"2781_CR193","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/mds.24993","volume":"27","author":"H Pouclet","year":"2012","unstructured":"Pouclet H, Lebouvier T, Coron E, Neunlist M, Derkinderen P (2012) Lewy pathology in gastric and duodenal biopsies in Parkinson\u2019s disease. Mov Disord 27:708. https:\/\/doi.org\/10.1002\/mds.24993","journal-title":"Mov Disord"},{"key":"2781_CR194","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/wnl.44.1.84","volume":"44","author":"JS Purba","year":"1994","unstructured":"Purba JS, Hofman MA, Swaab DF (1994) Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson\u2019s disease. Neurology 44:84\u201389. https:\/\/doi.org\/10.1212\/wnl.44.1.84","journal-title":"Neurology"},{"key":"2781_CR195","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/brain\/awab440","volume":"145","author":"S Rahayel","year":"2022","unstructured":"Rahayel S, Misic B, Zheng YQ, Liu ZQ, Abdelgawad A, Abbasi N et al (2022) Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns. Brain 145:1743\u20131756. https:\/\/doi.org\/10.1093\/brain\/awab440","journal-title":"Brain"},{"key":"2781_CR196","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1055\/s-0042-1758780","volume":"42","author":"S Rajan","year":"2022","unstructured":"Rajan S, Kaas B (2022) Parkinson\u2019s disease: risk factor modification and prevention. Semin Neurol 42:626\u2013638. https:\/\/doi.org\/10.1055\/s-0042-1758780","journal-title":"Semin Neurol"},{"key":"2781_CR197","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam N, Jin SX, Moors TE, Fonseca-Ornelas L, Shimanaka K, Lei S et al (2023) Dynamic physiological alpha-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Parkinsons Dis 9:4. https:\/\/doi.org\/10.1038\/s41531-023-00444-w","journal-title":"NPJ Parkinsons Dis"},{"key":"2781_CR198","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","volume":"12","author":"S Ray","year":"2020","unstructured":"Ray S, Singh N, Kumar R, Patel K, Pandey S, Datta D et al (2020) Alpha-synuclein aggregation nucleates through liquid-liquid phase separation. Nat Chem 12:705\u2013716. https:\/\/doi.org\/10.1038\/s41557-020-0465-9","journal-title":"Nat Chem"},{"key":"2781_CR199","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41557-023-01244-8","volume":"15","author":"S Ray","year":"2023","unstructured":"Ray S, Mason TO, Boyens-Thiele L, Farzadfard A, Larsen JA, Norrild RK et al (2023) Mass photometric detection and quantification of nanoscale alpha-synuclein phase separation. Nat Chem 15:1306\u20131316. https:\/\/doi.org\/10.1038\/s41557-023-01244-8","journal-title":"Nat Chem"},{"key":"2781_CR200","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B, Bove J, Carballo-Carbajal I, Dovero S, Perez-Villalba A et al (2014) Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 75:351\u2013362. https:\/\/doi.org\/10.1002\/ana.24066","journal-title":"Ann Neurol"},{"key":"2781_CR201","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ et al (2016) Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J Exp Med 213:1759\u20131778. https:\/\/doi.org\/10.1084\/jem.20160368","journal-title":"J Exp Med"},{"key":"2781_CR202","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","volume":"135","author":"NL Rey","year":"2018","unstructured":"Rey NL, George S, Steiner JA, Madaj Z, Luk KC, Trojanowski JQ et al (2018) Spread of aggregates after olfactory bulb injection of alpha-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol 135:65\u201383. https:\/\/doi.org\/10.1007\/s00401-017-1792-9","journal-title":"Acta Neuropathol"},{"key":"2781_CR203","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ana.21380","volume":"63","author":"OA Ross","year":"2008","unstructured":"Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton FA et al (2008) Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol 63:743\u2013750. https:\/\/doi.org\/10.1002\/ana.21380","journal-title":"Ann Neurol"},{"key":"2781_CR204","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.53111","author":"TR Sampson","year":"2020","unstructured":"Sampson TR, Challis C, Jain N, Moiseyenko A, Ladinsky MS, Shastri GG et al (2020) A gut bacterial amyloid promotes alpha-synuclein aggregation and motor impairment in mice. Elife. https:\/\/doi.org\/10.7554\/eLife.53111","journal-title":"Elife"},{"key":"2781_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13799","author":"N Samudra","year":"2024","unstructured":"Samudra N, Fischer DL, Lenio S, Lario Lago A, Ljubenkov PA, Rojas JC et al (2024) Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.13799","journal-title":"Alzheimers Dement"},{"key":"2781_CR206","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M et al (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat Genet 41:1303\u20131307. https:\/\/doi.org\/10.1038\/ng.485","journal-title":"Nat Genet"},{"issue":"1015\u20131030","key":"2781_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.028","volume":"174","author":"A Saunders","year":"2018","unstructured":"Saunders A, Macosko EZ, Wysoker A, Goldman M, Krienen FM, de Rivera H et al (2018) Molecular diversity and specializations among the cells of the adult mouse brain. Cell 174(1015\u20131030):e1016. https:\/\/doi.org\/10.1016\/j.cell.2018.07.028","journal-title":"Cell"},{"key":"2781_CR208","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/mds.29161","volume":"37","author":"M Sawamura","year":"2022","unstructured":"Sawamura M, Onoe H, Tsukada H, Isa K, Yamakado H, Okuda S et al (2022) Lewy body disease primate model with alpha-synuclein propagation from the olfactory bulb. Mov Disord 37:2033\u20132044. https:\/\/doi.org\/10.1002\/mds.29161","journal-title":"Mov Disord"},{"key":"2781_CR209","doi-asserted-by":"publisher","first-page":"10919","DOI":"10.1038\/s41598-019-47227-z","volume":"9","author":"AJ Schaser","year":"2019","unstructured":"Schaser AJ, Osterberg VR, Dent SE, Stackhouse TL, Wakeham CM, Boutros SW et al (2019) Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci Rep 9:10919. https:\/\/doi.org\/10.1038\/s41598-019-47227-z","journal-title":"Sci Rep"},{"key":"2781_CR210","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40478-020-01026-0","volume":"8","author":"AJ Schaser","year":"2020","unstructured":"Schaser AJ, Stackhouse TL, Weston LJ, Kerstein PC, Osterberg VR, Lopez CS et al (2020) Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy. Acta Neuropathol Commun 8:150. https:\/\/doi.org\/10.1186\/s40478-020-01026-0","journal-title":"Acta Neuropathol Commun"},{"issue":"5089\u20135106","key":"2781_CR211","doi-asserted-by":"publisher","first-page":"e5021","DOI":"10.1016\/j.cell.2021.09.007","volume":"184","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich H, Dansokho C, Mercan D, Schmidt SV, Bousset L, Wischhof L et al (2021) Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell 184(5089\u20135106):e5021. https:\/\/doi.org\/10.1016\/j.cell.2021.09.007","journal-title":"Cell"},{"key":"2781_CR212","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-023-06437-2","volume":"621","author":"SHW Scheres","year":"2023","unstructured":"Scheres SHW, Ryskeldi-Falcon B, Goedert M (2023) Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids. Nature 621:701\u2013710. https:\/\/doi.org\/10.1038\/s41586-023-06437-2","journal-title":"Nature"},{"key":"2781_CR213","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.pbr.2019.10.006","volume":"252","author":"AM Schonhoff","year":"2020","unstructured":"Schonhoff AM, Williams GP, Wallen ZD, Standaert DG, Harms AS (2020) Innate and adaptive immune responses in Parkinson\u2019s disease. Prog Brain Res 252:169-216. https:\/\/doi.org\/10.1016\/bs.pbr.2019.10.006","journal-title":"Prog Brain Res"},{"key":"2781_CR214","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00019052-199908000-00010","volume":"12","author":"JB Schulz","year":"1999","unstructured":"Schulz JB, Dichgans J (1999) Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration? Curr Opin Neurol 12:433\u2013439. https:\/\/doi.org\/10.1097\/00019052-199908000-00010","journal-title":"Curr Opin Neurol"},{"key":"2781_CR215","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","volume":"592","author":"B Schumacher","year":"2021","unstructured":"Schumacher B, Pothof J, Vijg J, Hoeijmakers JHJ (2021) The central role of DNA damage in the ageing process. Nature 592:695\u2013703. https:\/\/doi.org\/10.1038\/s41586-021-03307-7","journal-title":"Nature"},{"key":"2781_CR216","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B et al (2020) Structures of alpha-synuclein filaments from multiple system atrophy. Nature 585:464\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2317-6","journal-title":"Nature"},{"key":"2781_CR217","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","volume":"32","author":"D Scott","year":"2012","unstructured":"Scott D, Roy S (2012) alpha-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J Neurosci 32:10129\u201310135. https:\/\/doi.org\/10.1523\/JNEUROSCI.0535-12.2012","journal-title":"J Neurosci"},{"key":"2781_CR218","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","volume":"97","author":"LC Serpell","year":"2000","unstructured":"Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA (2000) Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci USA 97:4897\u20134902. https:\/\/doi.org\/10.1073\/pnas.97.9.4897","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR219","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP et al (2019) Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci 22:1099\u20131109. https:\/\/doi.org\/10.1038\/s41593-019-0423-2","journal-title":"Nat Neurosci"},{"key":"2781_CR220","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma M, Burre J (2023) alpha-Synuclein in synaptic function and dysfunction. Trends Neurosci 46:153\u2013166. https:\/\/doi.org\/10.1016\/j.tins.2022.11.007","journal-title":"Trends Neurosci"},{"key":"2781_CR221","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ncb2131","volume":"13","author":"M Sharma","year":"2011","unstructured":"Sharma M, Burre J, Sudhof TC (2011) CSPalpha promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity. Nat Cell Biol 13:30\u201339. https:\/\/doi.org\/10.1038\/ncb2131","journal-title":"Nat Cell Biol"},{"key":"2781_CR222","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA et al (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22:407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","journal-title":"Lancet Neurol"},{"key":"2781_CR223","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312. https:\/\/doi.org\/10.1038\/ng.487","journal-title":"Nat Genet"},{"key":"2781_CR224","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1474-4422(19)30319-9","volume":"19","author":"T Simuni","year":"2020","unstructured":"Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A et al (2020) Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson\u2019s Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol 19:71\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(19)30319-9","journal-title":"Lancet Neurol"},{"key":"2781_CR225","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M et al (2024) A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23:178\u2013190. https:\/\/doi.org\/10.1016\/S1474-4422(23)00405-2","journal-title":"Lancet Neurol"},{"key":"2781_CR226","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science"},{"key":"2781_CR227","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton AB, Farrer MJ, Bonifati V (2013) The genetics of Parkinson\u2019s disease: progress and therapeutic implications. Mov Disord 28:14\u201323. https:\/\/doi.org\/10.1002\/mds.25249","journal-title":"Mov Disord"},{"key":"2781_CR228","doi-asserted-by":"publisher","first-page":"168011","DOI":"10.1016\/j.jmb.2023.168011","volume":"435","author":"RWL So","year":"2023","unstructured":"So RWL, Watts JC (2023) Alpha-synuclein conformational strains as drivers of phenotypic heterogeneity in neurodegenerative diseases. J Mol Biol 435:168011. https:\/\/doi.org\/10.1016\/j.jmb.2023.168011","journal-title":"J Mol Biol"},{"key":"2781_CR229","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/s41467-020-17328-9","volume":"11","author":"FN Soria","year":"2020","unstructured":"Soria FN, Paviolo C, Doudnikoff E, Arotcarena ML, Lee A, Danne N et al (2020) Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling. Nat Commun 11:3440. https:\/\/doi.org\/10.1038\/s41467-020-17328-9","journal-title":"Nat Commun"},{"key":"2781_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2024.01.007","author":"C Soto","year":"2024","unstructured":"Soto C (2024) alpha-Synuclein seed amplification technology for Parkinson\u2019s disease and related synucleinopathies. Trends Biotechnol. https:\/\/doi.org\/10.1016\/j.tibtech.2024.01.007","journal-title":"Trends Biotechnol"},{"key":"2781_CR231","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tibs.2006.01.002","volume":"31","author":"C Soto","year":"2006","unstructured":"Soto C, Estrada L, Castilla J (2006) Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 31:150\u2013155. https:\/\/doi.org\/10.1016\/j.tibs.2006.01.002","journal-title":"Trends Biochem Sci"},{"key":"2781_CR232","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"2781_CR233","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95:6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR234","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) Alpha-synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2781_CR235","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jnc.14704","volume":"150","author":"L Stefanis","year":"2019","unstructured":"Stefanis L, Emmanouilidou E, Pantazopoulou M, Kirik D, Vekrellis K, Tofaris GK (2019) How is alpha-synuclein cleared from the cell? J Neurochem 150:577\u2013590. https:\/\/doi.org\/10.1111\/jnc.14704","journal-title":"J Neurochem"},{"key":"2781_CR236","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000477990","volume":"9","author":"E Stolzenberg","year":"2017","unstructured":"Stolzenberg E, Berry D, Yang D, Lee EY, Kroemer A, Kaufman S et al (2017) A role for neuronal alpha-synuclein in gastrointestinal immunity. J Innate Immun 9:456\u2013463. https:\/\/doi.org\/10.1159\/000477990","journal-title":"J Innate Immun"},{"key":"2781_CR237","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbi.2015.10.012","volume":"55","author":"WJ Streit","year":"2016","unstructured":"Streit WJ, Xue QS (2016) Microglia in dementia with Lewy bodies. Brain Behav Immun 55:191\u2013201. https:\/\/doi.org\/10.1016\/j.bbi.2015.10.012","journal-title":"Brain Behav Immun"},{"key":"2781_CR238","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM et al (2016) Induction of alpha-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies. Brain 139:481\u2013494. https:\/\/doi.org\/10.1093\/brain\/awv346","journal-title":"Brain"},{"key":"2781_CR239","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1073\/pnas.1903049116","volume":"116","author":"J Sun","year":"2019","unstructured":"Sun J, Wang L, Bao H, Premi S, Das U, Chapman ER et al (2019) Functional cooperation of alpha-synuclein and VAMP2 in synaptic vesicle recycling. Proc Natl Acad Sci USA 116:11113\u201311115. https:\/\/doi.org\/10.1073\/pnas.1903049116","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR240","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/bs.ircmb.2015.07.007","volume":"320","author":"A Surguchov","year":"2015","unstructured":"Surguchov A (2015) Intracellular dynamics of synucleins: \u201cHere, There and Everywhere.\u201d Int Rev Cell Mol Biol 320:103\u2013169. https:\/\/doi.org\/10.1016\/bs.ircmb.2015.07.007","journal-title":"Int Rev Cell Mol Biol"},{"key":"2781_CR241","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101\u2013113. https:\/\/doi.org\/10.1038\/nrn.2016.178","journal-title":"Nat Rev Neurosci"},{"key":"2781_CR242","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M et al (2011) Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 119:866\u2013872. https:\/\/doi.org\/10.1289\/ehp.1002839","journal-title":"Environ Health Perspect"},{"key":"2781_CR243","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"Tansey MG, Romero-Ramos M (2019) Immune system responses in Parkinson\u2019s disease: early and dynamic. Eur J Neurosci 49:364\u2013383. https:\/\/doi.org\/10.1111\/ejn.14290","journal-title":"Eur J Neurosci"},{"key":"2781_CR244","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"2781_CR245","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1471-4159.2006.04146.x","volume":"99","author":"R Tehranian","year":"2006","unstructured":"Tehranian R, Montoya SE, Van Laar AD, Hastings TG, Perez RG (2006) Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells. J Neurochem 99:1188\u20131196. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04146.x","journal-title":"J Neurochem"},{"key":"2781_CR246","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00702-017-1726-7","volume":"124","author":"JJ Tomlinson","year":"2017","unstructured":"Tomlinson JJ, Shutinoski B, Dong L, Meng F, Elleithy D, Lengacher NA et al (2017) Holocranohistochemistry enables the visualization of alpha-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects. J Neural Transm (Vienna) 124:721\u2013738. https:\/\/doi.org\/10.1007\/s00702-017-1726-7","journal-title":"J Neural Transm (Vienna)"},{"key":"2781_CR247","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1749-6632.2000.tb05561.x","volume":"924","author":"JQ Trojanowski","year":"2000","unstructured":"Trojanowski JQ, Lee VM (2000) \u201cFatal attractions\u201d of proteins. A comprehensive hypothetical mechanism underlying Alzheimer\u2019s disease and other neurodegenerative disorders. Ann N Y Acad Sci 924:62\u201367. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05561.x","journal-title":"Ann N Y Acad Sci"},{"key":"2781_CR248","doi-asserted-by":"publisher","first-page":"e13522","DOI":"10.1111\/acel.13522","volume":"20","author":"HY Tu","year":"2021","unstructured":"Tu HY, Yuan BS, Hou XO, Zhang XJ, Pei CS, Ma YT et al (2021) alpha-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson\u2019s disease. Aging Cell 20:e13522. https:\/\/doi.org\/10.1111\/acel.13522","journal-title":"Aging Cell"},{"key":"2781_CR249","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685\u2013697. https:\/\/doi.org\/10.1097\/01.jnen.0000225908.90052.07","journal-title":"J Neuropathol Exp Neurol"},{"key":"2781_CR250","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molmed.2020.03.012","volume":"26","author":"N Uemura","year":"2020","unstructured":"Uemura N, Uemura MT, Luk KC, Lee VM, Trojanowski JQ (2020) Cell-to-cell transmission of tau and alpha-synuclein. Trends Mol Med 26:936\u2013952. https:\/\/doi.org\/10.1016\/j.molmed.2020.03.012","journal-title":"Trends Mol Med"},{"key":"2781_CR251","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.1038\/s41467-023-42705-5","volume":"14","author":"N Uemura","year":"2023","unstructured":"Uemura N, Marotta NP, Ara J, Meymand ES, Zhang B, Kameda H et al (2023) Alpha-synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice. Nat Commun 14:6892. https:\/\/doi.org\/10.1038\/s41467-023-42705-5","journal-title":"Nat Commun"},{"key":"2781_CR252","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2579805\/v1","author":"N Uemura","year":"2023","unstructured":"Uemura N, Marotta N, Ara J, Meymand E, Zhang B, Kameda H et al (2023) Distinct biological activity of Lewy body alpha-synuclein strain in mice. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-2579805\/v1","journal-title":"Res Sq"},{"key":"2781_CR253","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.14336\/AD.2021.0516","volume":"12","author":"R Upadhya","year":"2021","unstructured":"Upadhya R, Shetty AK (2021) Extracellular vesicles for the diagnosis and treatment of Parkinson\u2019s disease. Aging Dis 12:1438\u20131450. https:\/\/doi.org\/10.14336\/AD.2021.0516","journal-title":"Aging Dis"},{"key":"2781_CR254","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/brain\/awab061","volume":"144","author":"N Van Den Berge","year":"2021","unstructured":"Van Den Berge N, Ferreira N, Mikkelsen TW, Alstrup AKO, Tamguney G, Karlsson P et al (2021) Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain 144:1853\u20131868. https:\/\/doi.org\/10.1093\/brain\/awab061","journal-title":"Brain"},{"key":"2781_CR255","doi-asserted-by":"publisher","first-page":"32486","DOI":"10.1074\/jbc.M110.139576","volume":"285","author":"J Varkey","year":"2010","unstructured":"Varkey J, Isas JM, Mizuno N, Jensen MB, Bhatia VK, Jao CC et al (2010) Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J Biol Chem 285:32486\u201332493. https:\/\/doi.org\/10.1074\/jbc.M110.139576","journal-title":"J Biol Chem"},{"key":"2781_CR256","doi-asserted-by":"publisher","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283:23542\u201323556. https:\/\/doi.org\/10.1074\/jbc.M801992200","journal-title":"J Biol Chem"},{"key":"2781_CR257","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nbd.2016.12.008","volume":"105","author":"LA Volpicelli-Daley","year":"2017","unstructured":"Volpicelli-Daley LA (2017) Effects of alpha-synuclein on axonal transport. Neurobiol Dis 105:321\u2013327. https:\/\/doi.org\/10.1016\/j.nbd.2016.12.008","journal-title":"Neurobiol Dis"},{"key":"2781_CR258","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A et al (2011) Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"key":"2781_CR259","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1091\/mbc.E14-02-0741","volume":"25","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Gamble KL, Schultheiss CE, Riddle DM, West AB, Lee VM (2014) Formation of alpha-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes. Mol Biol Cell 25:4010\u20134023. https:\/\/doi.org\/10.1091\/mbc.E14-02-0741","journal-title":"Mol Biol Cell"},{"issue":"Suppl 1","key":"2781_CR260","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jnc.13627","volume":"139","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA, Kirik D, Stoyka LE, Standaert DG, Harms AS (2016) How can rAAV-alpha-synuclein and the fibril alpha-synuclein models advance our understanding of Parkinson\u2019s disease? J Neurochem 139(Suppl 1):131\u2013155. https:\/\/doi.org\/10.1111\/jnc.13627","journal-title":"J Neurochem"},{"key":"2781_CR261","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jchemneu.2017.08.004","volume":"93","author":"CS von Bartheld","year":"2018","unstructured":"von Bartheld CS (2018) Myths and truths about the cellular composition of the human brain: a review of influential concepts. J Chem Neuroanat 93:2\u201315. https:\/\/doi.org\/10.1016\/j.jchemneu.2017.08.004","journal-title":"J Chem Neuroanat"},{"issue":"Suppl 2","key":"2781_CR262","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000113469","volume":"38","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in Parkinson\u2019s disease. Eur Neurol 38(Suppl 2):2\u20137","journal-title":"Eur Neurol"},{"key":"2781_CR263","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H (2013) The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol Neurobiol 47:495\u2013508. https:\/\/doi.org\/10.1007\/s12035-012-8280-y","journal-title":"Mol Neurobiol"},{"key":"2781_CR264","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"LC Walker","year":"2015","unstructured":"Walker LC, Jucker M (2015) Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci 38:87\u2013103. https:\/\/doi.org\/10.1146\/annurev-neuro-071714-033828","journal-title":"Annu Rev Neurosci"},{"key":"2781_CR265","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tins.2006.06.010","volume":"29","author":"LC Walker","year":"2006","unstructured":"Walker LC, Levine H 3rd, Mattson MP, Jucker M (2006) Inducible proteopathies. Trends Neurosci 29:438\u2013443. https:\/\/doi.org\/10.1016\/j.tins.2006.06.010","journal-title":"Trends Neurosci"},{"key":"2781_CR266","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","volume":"24","author":"L Wang","year":"2014","unstructured":"Wang L, Das U, Scott DA, Tang Y, McLean PJ, Roy S (2014) alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr Biol 24:2319\u20132326. https:\/\/doi.org\/10.1016\/j.cub.2014.08.027","journal-title":"Curr Biol"},{"key":"2781_CR267","doi-asserted-by":"publisher","first-page":"E1926","DOI":"10.1073\/pnas.1417883112","volume":"112","author":"S Wang","year":"2015","unstructured":"Wang S, Chu CH, Stewart T, Ginghina C, Wang Y, Nie H et al (2015) alpha-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation. Proc Natl Acad Sci USA 112:E1926-1935. https:\/\/doi.org\/10.1073\/pnas.1417883112","journal-title":"Proc Natl Acad Sci USA"},{"key":"2781_CR268","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00401-019-02058-0","volume":"138","author":"JC Watts","year":"2019","unstructured":"Watts JC (2019) Calling alpha-synuclein a prion is scientifically justifiable. Acta Neuropathol 138:505\u2013508. https:\/\/doi.org\/10.1007\/s00401-019-02058-0","journal-title":"Acta Neuropathol"},{"key":"2781_CR269","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1096\/fj.03-0152fje","volume":"17","author":"C Wersinger","year":"2003","unstructured":"Wersinger C, Prou D, Vernier P, Sidhu A (2003) Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J 17:2151\u20132153. https:\/\/doi.org\/10.1096\/fj.03-0152fje","journal-title":"FASEB J"},{"key":"2781_CR270","doi-asserted-by":"publisher","first-page":"105291","DOI":"10.1016\/j.nbd.2021.105291","volume":"152","author":"LJ Weston","year":"2021","unstructured":"Weston LJ, Cook ZT, Stackhouse TL, Sal MK, Schultz BI, Tobias ZJC et al (2021) In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129. Neurobiol Dis 152:105291. https:\/\/doi.org\/10.1016\/j.nbd.2021.105291","journal-title":"Neurobiol Dis"},{"key":"2781_CR271","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315294","author":"LJ Weston","year":"2022","unstructured":"Weston LJ, Bowman AM, Osterberg VR, Meshul CK, Woltjer RL, Unni VK (2022) Aggregated alpha-synuclein inclusions within the nucleus predict impending neuronal cell death in a mouse model of Parkinsonism. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232315294","journal-title":"Int J Mol Sci"},{"issue":"13 Suppl","key":"2781_CR272","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1513\/AnnalsATS.201602-095AW","volume":"5","author":"CM Weyand","year":"2016","unstructured":"Weyand CM, Goronzy JJ (2016) Aging of the immune system. Mechanisms and therapeutic targets. Ann Am Thorac Soc 5(13 Suppl):422\u2013428. https:\/\/doi.org\/10.1513\/AnnalsATS.201602-095AW","journal-title":"Ann Am Thorac Soc"},{"key":"2781_CR273","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, Wakefield LK et al (2004) Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 82:192\u2013207. https:\/\/doi.org\/10.1016\/j.ymgme.2004.04.011","journal-title":"Mol Genet Metab"},{"key":"2781_CR274","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/mds.27823","volume":"34","author":"YC Wong","year":"2019","unstructured":"Wong YC, Luk K, Purtell K, Burke Nanni S, Stoessl AJ, Trudeau LE et al (2019) Neuronal vulnerability in Parkinson disease: should the focus be on axons and synaptic terminals? Mov Disord 34:1406\u20131422. https:\/\/doi.org\/10.1002\/mds.27823","journal-title":"Mov Disord"},{"key":"2781_CR275","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00401-020-02227-6","volume":"140","author":"Q Wu","year":"2020","unstructured":"Wu Q, Shaikh MA, Meymand ES, Zhang B, Luk KC, Trojanowski JQ et al (2020) Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo. Acta Neuropathol 140:831\u2013849. https:\/\/doi.org\/10.1007\/s00401-020-02227-6","journal-title":"Acta Neuropathol"},{"key":"2781_CR276","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mds.29363","volume":"38","author":"TA Yacoubian","year":"2023","unstructured":"Yacoubian TA, Fang YD, Gerstenecker A, Amara A, Stover N, Ruffrage L, Collette C, Kennedy R, Zhang Y, Hong Het al (2023) Brain and Systemic Inflammation in De Novo Parkinson\u2019s Disease. Mov Disord 38:743\u2013754. https:\/\/doi.org\/10.1002\/mds.29363","journal-title":"Mov Disord"},{"key":"2781_CR277","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173. https:\/\/doi.org\/10.1002\/ana.10795","journal-title":"Ann Neurol"},{"key":"2781_CR278","doi-asserted-by":"publisher","first-page":"e13196","DOI":"10.1111\/bpa.13196","volume":"33","author":"S Zhang","year":"2023","unstructured":"Zhang S, Dauer K, Strohaker T, Tatenhorst L, Caldi Gomes L, Mayer S et al (2023) Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson\u2019s disease patient brain spread after intracerebral injection into mouse brain. Brain Pathol 33:e13196. https:\/\/doi.org\/10.1111\/bpa.13196","journal-title":"Brain Pathol"},{"key":"2781_CR279","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1749-6632.1992.tb24525.x","volume":"648","author":"MJ Zigmond","year":"1992","unstructured":"Zigmond MJ, Hastings TG, Abercrombie ED (1992) Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson\u2019s disease. Ann N Y Acad Sci 648:71\u201386. https:\/\/doi.org\/10.1111\/j.1749-6632.1992.tb24525.x","journal-title":"Ann N Y Acad Sci"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02781-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-024-02781-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02781-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:02:28Z","timestamp":1723647748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-024-02781-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":279,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2781"],"URL":"https:\/\/doi.org\/10.1007\/s00401-024-02781-3","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}